Health in Code develops an innovative diagnostic method for hereditary alpha tryptasemia, an immune-related disorder
Madrid, December 30, 2024. Health in Code’s R+D team has developed a groundbreaking method [...]
Dec
Immunodeficiencies considered secondary to hematological malignancies could be inborn errors of immunity
Our Immunology team has published a new paper in the Journal of Clinical Immunology in [...]
Nov
New gene potentially related to primary immunodeficiency and predisposition to hematological malignancies
Our Immunology Team has presented their work in collaboration with San Carlos Clinical Hospital, in [...]
Oct
Treatment personalization in breast cancer: MammaPrint allows predicting the benefit from extended endocrine therapy
A new study published in the Journal of Clinical Oncology has concluded that patients classified [...]
Sep
Health in Code helps reveal that 50% of chronic kidney diseases of unknown origin have a genetic component
• A groundbreaking study in Spain has analyzed the potential genetic causes of idiopathic (i.e. [...]
Aug
HRD testing allows identifying ovarian cancer patients who may benefit from PARP inhibitor therapy
Homologous recombination deficiency (HRD) is the loss of one of the DNA repair systems on [...]
Aug